Qsymia Capsule, Extended Release
Product Images NDC 62541-201

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Qsymia (NDC 62541-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vivus Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Qsymia 01)

A body mass index (BMI) chart displaying weight ranges in pounds and kilograms across the top, height in inches and centimeters along the left side, with cells containing corresponding BMI values. Certain BMI values are highlighted in green. This table assists in assessing BMI based on height and weight measurements.*

FDA Label Image

Chemical Structure (Qsymia 02)

Chemical structure of phentermine hydrochloride, illustrating the molecular formula with a phenyl ring, amine group, and hydrochloride component.*

FDA Label Image

Chemical Structure (Qsymia 03)

Chemical structure of phentermine and topiramate, the active ingredients in Qsymia extended-release capsules. The diagram shows the molecular arrangement of the compound, including rings and functional groups typical for this pharmaceutical ingredient.*

FDA Label Image

Studies 1 And 2 (Qsymia 04)

Two line graphs showing percent weight loss over time (in weeks) from two studies of Qsymia capsules. Each graph compares placebo and Qsymia extended release capsules at different dosages: Study 1 with 3.75 mg/23 mg and 15 mg/92 mg, and Study 2 with 7.5 mg/46 mg and 15 mg/92 mg. Both graphs depict greater weight loss with Qsymia versus placebo across 56 weeks.*

FDA Label Image

Figures A-d (Qsymia 05)

Illustration of Qsymia extended-release capsules in four strength variants: 3.75 mg/23 mg with a purple cap and body with white printing; 7.5 mg/46 mg with a purple cap with white printing and yellow body with black printing; 11.25 mg/69 mg with a yellow cap and body with black printing; 15 mg/92 mg with a yellow cap with black printing and white body with black printing. Capsules are labeled with "VIVUS" and their respective strength.*

FDA Label Image

Principal Display Panel (3.75 mg/23 mg Capsule Bottle Label)

Label for Qsymia 7.5 mg/46 mg extended-release capsules by Vivus LLC. The label shows the product name and active ingredients phentermine and topiramate. It indicates 30 capsules per container with dosage information and storage instructions. The capsule is described as purple and yellow with specific imprint details.*

FDA Label Image

Principal Display Panel (7.5 mg/46 mg Capsule Bottle Label)

Qsymia 3.75 mg/23 mg extended-release capsules label from Vivus LLC. The label shows the product name, active ingredients phentermine and topiramate, and dosage strength. It includes storage instructions, quantity of 30 capsules, and capsule description: purple capsules with "VIVUS" and strength printed in white on the purple body. The label also displays a barcode and medication guide statement.*

FDA Label Image

Principal Display Panel (15 mg/92 mg Capsule Bottle Label)

Label for Qsymia 15 mg/92 mg extended-release capsules containing phentermine and topiramate, manufactured by Vivus LLC. The label specifies a package of 30 capsules, with storage instructions at room temperature and a description of the capsule appearance. The yellow cap is marked with 'VIVUS' and the white body with '15/92' in black print. Includes a barcode and dispensing instructions.*

FDA Label Image

Principal Display Panel (11.25 mg/69 mg Capsule Bottle Label)

Qsymia 11.25 mg/69 mg extended-release capsules label showing the brand name and active ingredients phentermine and topiramate. The label indicates the package contains 30 capsules and includes storage instructions, manufacturer Vivus LLC, and a barcode. The capsules are identified by a yellow color with "VIVUS" and the dosage printed in black.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.